In HF, angiotensin-neprilysin inhibition reduced mortality and HF hospitalization compared with enalapril.

In HF, angiotensin-neprilysin inhibition reduced mortality and HF hospitalization compared with enalapril. Ann Intern Med. 2015 Feb 17;162(4):JC2 Authors: Schmitt BP PMID: 25686189 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/25686189?dopt=Abstract

Source: Annals of Internal Medicine - February 17, 2015 Category: Internal Medicine Authors: Schmitt BP Tags: Ann Intern Med Source Type: research

More News: Enalapril | Internal Medicine